Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1416 | 2674 | 30.8 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
203 | 3 | STREPTOCOCCUS PNEUMONIAE//OTITIS MEDIA//OTORHINOLARYNGOLOGY | 52559 |
1203 | 2 | PERTUSSIS//BORDETELLA PERTUSSIS//PASTEURELLA MULTOCIDA | 9207 |
1416 | 1 | PERTUSSIS//BORDETELLA PERTUSSIS//WHOOPING COUGH | 2674 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PERTUSSIS | authKW | 4840343 | 23% | 69% | 616 |
2 | BORDETELLA PERTUSSIS | authKW | 1941074 | 12% | 53% | 321 |
3 | WHOOPING COUGH | authKW | 1595771 | 7% | 73% | 191 |
4 | ACELLULAR PERTUSSIS VACCINE | authKW | 835310 | 4% | 71% | 103 |
5 | PERTUSSIS VACCINE | authKW | 478159 | 3% | 53% | 79 |
6 | WHOLE CELL PERTUSSIS VACCINE | authKW | 347304 | 1% | 78% | 39 |
7 | ACELLULAR VACCINE | authKW | 343462 | 1% | 79% | 38 |
8 | PERTUSSIS REFERENCE | address | 207588 | 1% | 91% | 20 |
9 | TDAP | authKW | 202668 | 1% | 51% | 35 |
10 | BORDETELLA HOLMESII | authKW | 194697 | 1% | 95% | 18 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 33307 | 33% | 0% | 892 |
2 | Immunology | 15048 | 36% | 0% | 974 |
3 | Pediatrics | 10542 | 22% | 0% | 592 |
4 | Microbiology | 9455 | 26% | 0% | 683 |
5 | Medicine, Research & Experimental | 3636 | 15% | 0% | 391 |
6 | Medicine, General & Internal | 1136 | 11% | 0% | 294 |
7 | Public, Environmental & Occupational Health | 599 | 7% | 0% | 199 |
8 | BIOLOGY, MISCELLANEOUS | 111 | 0% | 0% | 4 |
9 | Primary Health Care | 78 | 1% | 0% | 17 |
10 | Biology | 37 | 2% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PERTUSSIS REFERENCE | 207588 | 1% | 91% | 20 |
2 | HYG MED | 150977 | 1% | 58% | 23 |
3 | REFERENCE BORDETELLA | 92480 | 0% | 90% | 9 |
4 | REFERENCE COQUELUCHE AUT BORDETELLO | 86338 | 0% | 69% | 11 |
5 | HYG ORMED | 57088 | 0% | 100% | 5 |
6 | REFERENCE WHOOPING COUGH OTHER BORDETE | 57088 | 0% | 100% | 5 |
7 | INFECT DIS SCREENING LIS | 51376 | 0% | 75% | 6 |
8 | UNITE BORDETELLA | 51370 | 0% | 50% | 9 |
9 | MOL PREVENT THER Y HUMAN DIS UNIT | 50855 | 0% | 64% | 7 |
10 | UNITE PREVENT THER IES MOL MALAD HUMAINES | 48665 | 0% | 47% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 66324 | 12% | 2% | 324 |
2 | PEDIATRIC INFECTIOUS DISEASE JOURNAL | 36651 | 6% | 2% | 173 |
3 | DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION | 27020 | 1% | 6% | 37 |
4 | EXPERT REVIEW OF VACCINES | 9344 | 1% | 3% | 32 |
5 | CLINICAL INFECTIOUS DISEASES | 8418 | 4% | 1% | 98 |
6 | JOURNAL OF CLINICAL MICROBIOLOGY | 6909 | 5% | 0% | 128 |
7 | CLINICAL AND VACCINE IMMUNOLOGY | 6881 | 1% | 2% | 40 |
8 | PEDIATRICS | 5282 | 4% | 1% | 95 |
9 | MEDECINE ET MALADIES INFECTIEUSES | 4766 | 1% | 1% | 40 |
10 | EPIDEMIOLOGY AND INFECTION | 4293 | 2% | 1% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PERTUSSIS | 4840343 | 23% | 69% | 616 | Search PERTUSSIS | Search PERTUSSIS |
2 | BORDETELLA PERTUSSIS | 1941074 | 12% | 53% | 321 | Search BORDETELLA+PERTUSSIS | Search BORDETELLA+PERTUSSIS |
3 | WHOOPING COUGH | 1595771 | 7% | 73% | 191 | Search WHOOPING+COUGH | Search WHOOPING+COUGH |
4 | ACELLULAR PERTUSSIS VACCINE | 835310 | 4% | 71% | 103 | Search ACELLULAR+PERTUSSIS+VACCINE | Search ACELLULAR+PERTUSSIS+VACCINE |
5 | PERTUSSIS VACCINE | 478159 | 3% | 53% | 79 | Search PERTUSSIS+VACCINE | Search PERTUSSIS+VACCINE |
6 | WHOLE CELL PERTUSSIS VACCINE | 347304 | 1% | 78% | 39 | Search WHOLE+CELL+PERTUSSIS+VACCINE | Search WHOLE+CELL+PERTUSSIS+VACCINE |
7 | ACELLULAR VACCINE | 343462 | 1% | 79% | 38 | Search ACELLULAR+VACCINE | Search ACELLULAR+VACCINE |
8 | TDAP | 202668 | 1% | 51% | 35 | Search TDAP | Search TDAP |
9 | BORDETELLA HOLMESII | 194697 | 1% | 95% | 18 | Search BORDETELLA+HOLMESII | Search BORDETELLA+HOLMESII |
10 | PERTACTIN | 186463 | 1% | 58% | 28 | Search PERTACTIN | Search PERTACTIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KILGORE, PE , SALIM, AM , ZERVOS, MJ , SCHMITT, HJ , (2016) PERTUSSIS: MICROBIOLOGY, DISEASE, TREATMENT, AND PREVENTION.CLINICAL MICROBIOLOGY REVIEWS. VOL. 29. ISSUE 3. P. 449 -486 | 289 | 60% | 6 |
2 | VAN DER ZEE, A , SCHELLEKENS, JFP , MOOI, FR , (2015) LABORATORY DIAGNOSIS OF PERTUSSIS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 28. ISSUE 4. P. 1005 -1026 | 198 | 89% | 8 |
3 | CROWCROFT, NS , PEBODY, RG , (2006) RECENT DEVELOPMENTS IN PERTUSSIS.LANCET. VOL. 367. ISSUE 9526. P. 1926-1936 | 118 | 98% | 136 |
4 | MATTOO, S , CHERRY, JD , (2005) MOLECULAR PATHOGENESIS, EPIDEMIOLOGY, AND CLINICAL MANIFESTATIONS OF RESPIRATORY INFECTIONS DUE TO BORDETELLA PERTUSSIS AND OTHER BORDETELLA SUBSPECIES.CLINICAL MICROBIOLOGY REVIEWS. VOL. 18. ISSUE 2. P. 326-+ | 211 | 41% | 472 |
5 | SALIM, AM , LIANG, Y , KILGORE, PE , (2015) PROTECTING NEWBORNS AGAINST PERTUSSIS: TREATMENT AND PREVENTION STRATEGIES.PEDIATRIC DRUGS. VOL. 17. ISSUE 6. P. 425 -441 | 113 | 82% | 0 |
6 | ZHANG, LJ , PRIETSCH, SOM , AXELSSON, I , HALPERIN, SA , (2014) ACELLULAR VACCINES FOR PREVENTING WHOOPING COUGH IN CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 92 | 93% | 3 |
7 | BARKOFF, AM , GRONDAHL-YLI-HANNUKSELA, K , HE, QS , (2015) SEROPREVALENCE STUDIES OF PERTUSSIS: WHAT HAVE WE LEARNED FROM DIFFERENT IMMUNIZED POPULATIONS.PATHOGENS AND DISEASE. VOL. 73. ISSUE 7. P. - | 80 | 94% | 5 |
8 | ZHANG, LJ , PRIETSCH, SOM , AXELSSON, I , HALPERIN, SA , (2012) ACELLULAR VACCINES FOR PREVENTING WHOOPING COUGH IN CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 92 | 92% | 5 |
9 | ZOUARI, A , SMAOUI, H , KECHRID, A , (2012) THE DIAGNOSIS OF PERTUSSIS: WHICH METHOD TO CHOOSE?.CRITICAL REVIEWS IN MICROBIOLOGY. VOL. 38. ISSUE 2. P. 111 -121 | 87 | 93% | 8 |
10 | ZEPP, F , HEININGER, U , MERTSOLA, J , BERNATOWSKA, E , GUISO, N , ROORD, J , TOZZI, AE , VAN DAMME, P , (2011) RATIONALE FOR PERTUSSIS BOOSTER VACCINATION THROUGHOUT LIFE IN EUROPE.LANCET INFECTIOUS DISEASES. VOL. 11. ISSUE 7. P. 557 -570 | 69 | 93% | 93 |
Classes with closest relation at Level 1 |